VOLITIONRX LTD — Director's Dealing 2016

Nov 28, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-11-25

Reporting Person: Faulkes Martin Charles (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-25	Common Stock	M	5000	$3	Acquired	1296629	Direct
2016-11-25	Common Stock	F	3379	$4.44	Disposed	1293250	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-25	Stock Option (Right to Buy)	$3	M	5000	Disposed	2016-11-25	Common Stock (5000)	Direct

Footnotes

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction.